These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 7919586

  • 21. Genetic contributors toward increased risk for ischemic heart disease.
    Nordlie MA, Wold LE, Kloner RA.
    J Mol Cell Cardiol; 2005 Oct; 39(4):667-79. PubMed ID: 16087188
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH.
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [Abstract] [Full Text] [Related]

  • 29. [Secondary prevention of ischemic cardiopathy].
    Caruzzo E, Caruzzo C.
    Cardiologia; 1995 May; 40(5):347-53. PubMed ID: 8529246
    [No Abstract] [Full Text] [Related]

  • 30. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W, Forder P, Simes J, Hunt D, Tonkin A, LIPID Investigators.
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
    Carević V, Rumboldt M, Rumboldt Z, Interheart Investigators.
    Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
    [Abstract] [Full Text] [Related]

  • 37. Secondary prevention for ischemic heart disease. Relative numbers needed to treat with different therapies.
    Miller DB.
    Arch Intern Med; 1997 Oct 13; 157(18):2045-52. PubMed ID: 9382659
    [Abstract] [Full Text] [Related]

  • 38. [Treatment of hyperlipidemia. Guidelines for treatment of hyperlipidemia for secondary prevention of ischemic heart disease].
    Ose L.
    Tidsskr Nor Laegeforen; 1995 Nov 30; 115(29):3629-31. PubMed ID: 8539720
    [Abstract] [Full Text] [Related]

  • 39. A female pattern of ischemic heart disease--a new look at an old problem.
    Janion-Sadowska A, Sadowski M, Janion M.
    Przegl Lek; 2012 Nov 30; 69(2):76-9. PubMed ID: 22768418
    [Abstract] [Full Text] [Related]

  • 40. Ischemic heart disease in women: a review for primary care physicians.
    Kusnoor AV, Ferguson AD, Falik R.
    South Med J; 2011 Mar 30; 104(3):200-4. PubMed ID: 21297529
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.